Ask the Expert: Question about immunotherapy

Question: Has immunotherapy improved outcomes in head and neck cancer? What’s on the horizon with clinical trials?

Response: It has, particularly in the recurrent and metastatic setting. This article from AACR sums the latest findings in head and neck cancer:
http://www.aacr.org/Newsroom/Pages/News-Release-Detail.aspx?ItemID=882#.WAAVuDspo9s

Dr. Kang is an Assistant Professor in the Department of Otolaryngology – Head & Neck Surgery at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) , specializing in the comprehensive management of benign and malignant head and neck tumors. Click the following links to learn more about Dr. Kang and the OSUCCC– James: https://cancer.osu.edu/find-a-doctor/search-physician-directory/stephen-y-kang and https://cancer.osu.edu/.

The Ask the Expert Guest Moderator is not intended to be a substitute for healthcare professional medical advice, diagnosis, or treatment. Speak to your healthcare provider about any questions you may have regarding your health.